ArticleEuropean journal of nutrition2021

S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammation.

Qian Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.